P21
P21 (CNTF Mimetic Peptide)
P21 is a synthetic peptide derived from the active region of Ciliary Neurotrophic Factor (CNTF), designed to mimic its neuroprotective and neurogenic effects without requiring receptor complex binding. It is primarily investigated for its potential to enhance neurogenesis, improve cognitive function, and protect against neurodegenerative conditions including Alzheimer's disease and age-related cognitive decline.
Mechanism of Action
P21 activates the JAK/STAT3 signaling pathway by binding to the CNTFRα receptor subunit, promoting neural stem cell proliferation and differentiation in the hippocampus and other brain regions. It upregulates CNTF-responsive genes involved in neuronal survival and synaptic plasticity while also reducing amyloid precursor protein processing, potentially lowering Aβ accumulation. Additionally, P21 modulates BDNF expression and supports dendritic spine density, contributing to its cognitive-enhancing effects.
Evidence by Health Goal(16 goals)
Dosing Protocols
Morning, preferably post-workout or upon waking
Cycle: 4-6 weeks on, 2-4 weeks off
Subcutaneous injection is the most studied route. Start at 100mcg to assess tolerability before titrating upward. Some protocols use 5 days on, 2 days off within the cycle.
Morning on empty stomach for optimal CNS absorption
Cycle: 4-6 weeks on, 2-4 weeks off
Intranasal delivery may improve CNS bioavailability by bypassing the blood-brain barrier via olfactory pathways. Bioavailability compared to subcutaneous injection is not fully established in human data.
Safety & Side Effects
P21 has a relatively limited human safety dataset, with most evidence derived from rodent studies and limited anecdotal human use; it should be approached with caution given the lack of clinical trials establishing safe dosing ranges in humans. It is not approved by the FDA or regulatory equivalents, is sold strictly as a research compound, and individuals with a history of hormone-sensitive cancers, active CNS conditions, or those on immunomodulatory therapy should avoid use without medical supervision.
Possible Side Effects
- !Injection site redness, mild swelling, or irritation
- !Transient headache, particularly during initial dosing period
- !Mild fatigue or lethargy in some users, especially at higher doses
- !Sleep disturbances or vivid dreaming, possibly related to enhanced neuronal activity
- !Appetite suppression, consistent with CNTF's known anorectic signaling
- !Mild nausea at doses above 300mcg
- !Potential mood alterations including transient anxiety or emotional blunting
Interactions
- -May potentiate effects of other nootropic peptides (e.g., Semax, Selank) - combination increases CNS activity unpredictably
- -Concurrent use with BDNF-modulating compounds (e.g., NSI-189, 7,8-DHF) may produce additive neurogenic effects with unknown safety implications
- -Potential interaction with SSRI or SNRI antidepressants due to overlapping serotonergic and neuroplasticity pathways
- -May enhance insulin sensitivity - use caution in diabetic individuals on hypoglycemic medications
- -Theoretical interaction with corticosteroids, which suppress STAT3 signaling and may blunt P21 efficacy
Cost & Where to Buy
Pricing varies significantly by vendor purity, peptide grade, and vial concentration. At 200mcg/day for 30 days, a 5mg vial from a reputable research peptide supplier typically costs $50-100. Intranasal formulations may cost slightly more due to preparation requirements.
Search on Amazon